CFM
GSK icon

Cornerstone Financial Management’s GSK GSK Stock Holding History

Cornerstone Financial Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7K Buy
243
+113
+87% +$5.98K 0.01% 398
2026
Q1 		$7.17K Buy
130
+37
+40% +$2K 0.01% 385
2025
Q4 		$4.56K Buy
+93
New +$4.34K ﹤0.01% 450

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Cornerstone Financial Management's GSK Position: Q2 2026 in Review

Cornerstone Financial Management increased its GSK (GSK) stake by 87% in Q2 2026, buying an estimated $5.98K and bringing the position to 243 shares worth $12.7K. The position accounts for 0.01% of the portfolio, ranked #398.

Cornerstone Financial Management first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Cornerstone Financial Management held 243 shares of GSK worth $12.7K as of Q2 2026.
  • Cornerstone Financial Management bought 113 GSK shares in Q2 2026, an estimated $5.98K.
  • GSK made up 0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #398 holding.
  • Cornerstone Financial Management first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.